AU2008246442B2 - Engineered rabbit antibody variable domains and uses thereof - Google Patents

Engineered rabbit antibody variable domains and uses thereof Download PDF

Info

Publication number
AU2008246442B2
AU2008246442B2 AU2008246442A AU2008246442A AU2008246442B2 AU 2008246442 B2 AU2008246442 B2 AU 2008246442B2 AU 2008246442 A AU2008246442 A AU 2008246442A AU 2008246442 A AU2008246442 A AU 2008246442A AU 2008246442 B2 AU2008246442 B2 AU 2008246442B2
Authority
AU
Australia
Prior art keywords
thr
ser
gly
ala
leu
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2008246442A
Other languages
English (en)
Other versions
AU2008246442A1 (en
Inventor
Joao Manuel Braz Goncalves
Frederico Nuno Castanheira Aires Da Silva
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Technophage Investigacao e Desenvolvimento em Biotecnologia SA
Original Assignee
Technophage Investigacao e Desenvolvimento em Biotecnologia SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Technophage Investigacao e Desenvolvimento em Biotecnologia SA filed Critical Technophage Investigacao e Desenvolvimento em Biotecnologia SA
Publication of AU2008246442A1 publication Critical patent/AU2008246442A1/en
Application granted granted Critical
Publication of AU2008246442B2 publication Critical patent/AU2008246442B2/en
Priority to AU2014227505A priority Critical patent/AU2014227505A1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/567—Framework region [FR]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
AU2008246442A 2007-05-04 2008-04-30 Engineered rabbit antibody variable domains and uses thereof Active AU2008246442B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2014227505A AU2014227505A1 (en) 2007-05-04 2014-09-18 Engineered rabbit antibody variable domains and uses thereof

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US91622607P 2007-05-04 2007-05-04
US60/916,226 2007-05-04
PCT/PT2008/000018 WO2008136694A1 (en) 2007-05-04 2008-04-30 Engineered rabbit antibody variable domains and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2014227505A Division AU2014227505A1 (en) 2007-05-04 2014-09-18 Engineered rabbit antibody variable domains and uses thereof

Publications (2)

Publication Number Publication Date
AU2008246442A1 AU2008246442A1 (en) 2008-11-13
AU2008246442B2 true AU2008246442B2 (en) 2014-07-03

Family

ID=39735911

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2008246442A Active AU2008246442B2 (en) 2007-05-04 2008-04-30 Engineered rabbit antibody variable domains and uses thereof

Country Status (9)

Country Link
US (2) US10280211B2 (https=)
EP (1) EP2164868B1 (https=)
JP (3) JP5791895B2 (https=)
AU (1) AU2008246442B2 (https=)
CA (1) CA2685213C (https=)
ES (1) ES2540807T3 (https=)
PT (1) PT2164868E (https=)
SG (1) SG194368A1 (https=)
WO (1) WO2008136694A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2013205658B2 (en) * 2012-02-29 2015-04-16 Otsuka Pharmaceutical Co., Ltd. Anti - Lipoarabinomannan antibody and immunoassay for acid - fast bacillary infection using the antibody
US10654917B2 (en) 2015-01-29 2020-05-19 Technophage, Investigacao E Desenvolvimento Em Biotecnologia, Sa Antibody molecules and peptide delivery systems for use in alzheimer's disease and related disorders
US11685773B2 (en) 2015-04-30 2023-06-27 Abcheck S.R.O. Method for mass humanization of rabbit antibodies
SMT202000633T1 (it) * 2015-06-19 2021-01-05 Eisai R&D Man Co Ltd Immunoglobuline coniugate a cys80
US20210221915A1 (en) * 2018-06-08 2021-07-22 Ventana Medical Systems, Inc. Universal or normalized antibody frameworks for improved functionality and manufacturability
CA3231704A1 (en) * 2021-09-13 2023-03-16 The Board Of Regents Of The University Of Texas System Trem2 antigen binding proteins and uses thereof

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001030393A2 (en) * 1999-10-22 2001-05-03 Ludwig Institute For Cancer Research Methods for reducing the effects of cancers that express a33 antigen using a33 antigen specific immunoglobulin products
WO2001031065A1 (en) * 1999-10-22 2001-05-03 The Scripps Research Institute Humanization of non-human, mammalian antibodies
WO2004016740A2 (en) * 2002-08-15 2004-02-26 Epitomics, Inc. Humanized rabbit antibodies
WO2004091543A2 (en) * 2003-03-04 2004-10-28 Alexion Pharmaceuticals, Inc. Method of treating autoimmune disease by inducing antigen presentation by tolerance inducing antigen presenting cells
US20050048578A1 (en) * 2003-06-26 2005-03-03 Epitomics, Inc. Methods of screening for monoclonal antibodies with desirable activity
WO2006073748A2 (en) * 2004-12-17 2006-07-13 Alexion Pharmaceuticals, Inc. Antibodies against antigen presenting cells and uses thereof
US20060216293A1 (en) * 2005-03-24 2006-09-28 Couto Fernando J R TNFalpha-neutralizing antibodies
WO2008004834A1 (en) * 2006-07-06 2008-01-10 Isu Abxis Co., Ltd Humanized monoclonal antibody highly binding to epidermal growth factor receptor, egf receptor
WO2008016950A2 (en) * 2006-07-31 2008-02-07 Sandisk 3D Llc Method and apparatus for memory array incorporating two data busses for memory array block selection

Family Cites Families (89)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US598520A (en) 1898-02-08 Marker s record for laundrymen
US4741900A (en) 1982-11-16 1988-05-03 Cytogen Corporation Antibody-metal ion complexes
GB8308235D0 (en) 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
GB8314362D0 (en) 1983-05-24 1983-06-29 Celltech Ltd Polypeptide and protein products
US4544545A (en) 1983-06-20 1985-10-01 Trustees University Of Massachusetts Liposomes containing modified cholesterol for organ targeting
US5807715A (en) 1984-08-27 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin
US4676980A (en) 1985-09-23 1987-06-30 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Target specific cross-linked heteroantibodies
US5225539A (en) 1986-03-27 1993-07-06 Medical Research Council Recombinant altered antibodies and methods of making altered antibodies
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
JP3101690B2 (ja) 1987-03-18 2000-10-23 エス・ビィ・２・インコーポレイテッド 変性抗体の、または変性抗体に関する改良
US4880078A (en) 1987-06-29 1989-11-14 Honda Giken Kogyo Kabushiki Kaisha Exhaust muffler
US5336603A (en) 1987-10-02 1994-08-09 Genentech, Inc. CD4 adheson variants
EP0436597B1 (en) 1988-09-02 1997-04-02 Protein Engineering Corporation Generation and selection of recombinant varied binding proteins
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
KR900005995A (ko) 1988-10-31 1990-05-07 우메모또 요시마사 변형 인터류킨-2 및 그의 제조방법
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
US20040049014A1 (en) 1988-12-28 2004-03-11 Protein Design Labs, Inc. Humanized immunoglobulins
US5112946A (en) 1989-07-06 1992-05-12 Repligen Corporation Modified pf4 compositions and methods of use
US5013556A (en) 1989-10-20 1991-05-07 Liposome Technology, Inc. Liposomes with enhanced circulation time
WO1991006570A1 (en) 1989-10-25 1991-05-16 The University Of Melbourne HYBRID Fc RECEPTOR MOLECULES
GB8928874D0 (en) 1989-12-21 1990-02-28 Celltech Ltd Humanised antibodies
AU7247191A (en) 1990-01-11 1991-08-05 Molecular Affinities Corporation Production of antibodies using gene libraries
US5780225A (en) 1990-01-12 1998-07-14 Stratagene Method for generating libaries of antibody genes comprising amplification of diverse antibody DNAs and methods for using these libraries for the production of diverse antigen combining molecules
US5314995A (en) 1990-01-22 1994-05-24 Oncogen Therapeutic interleukin-2-antibody based fusion proteins
US5427908A (en) 1990-05-01 1995-06-27 Affymax Technologies N.V. Recombinant library screening methods
US5349053A (en) 1990-06-01 1994-09-20 Protein Design Labs, Inc. Chimeric ligand/immunoglobulin molecules and their uses
FI85768C (fi) 1990-07-04 1992-05-25 Valtion Teknillinen Foerfarande foer utfoerning av ytplasmonresonansmaetning samt i foerfarandet anvaendbar givare.
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
US5698426A (en) 1990-09-28 1997-12-16 Ixsys, Incorporated Surface expression libraries of heteromeric receptors
CA2095633C (en) 1990-12-03 2003-02-04 Lisa J. Garrard Enrichment method for variant proteins with altered binding properties
WO1992010591A1 (en) 1990-12-14 1992-06-25 Cell Genesys, Inc. Chimeric chains for receptor-associated signal transduction pathways
ATE414768T1 (de) 1991-04-10 2008-12-15 Scripps Research Inst Bibliotheken heterodimerer rezeptoren mittels phagemiden
CA2109528A1 (en) 1991-05-01 1992-11-02 Gregory A. Prince A method for treating infectious respiratory diseases
EP0519596B1 (en) 1991-05-17 2005-02-23 Merck & Co. Inc. A method for reducing the immunogenicity of antibody variable domains
DE69110032T2 (de) 1991-06-08 1995-12-21 Hewlett Packard Gmbh Verfahren und Gerät zur Feststellung und/oder Konzentrationsbestimmung von Biomolekülen.
EP1400536A1 (en) 1991-06-14 2004-03-24 Genentech Inc. Method for making humanized antibodies
US5565332A (en) 1991-09-23 1996-10-15 Medical Research Council Production of chimeric antibodies - a combinatorial approach
PT1024191E (pt) 1991-12-02 2008-12-22 Medical Res Council Produção de auto-anticorpos a partir de reportórios de segmentos de anticorpo e exibidos em fagos
EP0571613B1 (en) 1991-12-13 2003-09-17 Xoma Corporation Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
US5622929A (en) 1992-01-23 1997-04-22 Bristol-Myers Squibb Company Thioether conjugates
GB9203459D0 (en) 1992-02-19 1992-04-08 Scotgen Ltd Antibodies with germ-line variable regions
US5714350A (en) 1992-03-09 1998-02-03 Protein Design Labs, Inc. Increasing antibody affinity by altering glycosylation in the immunoglobulin variable region
US5733743A (en) 1992-03-24 1998-03-31 Cambridge Antibody Technology Limited Methods for producing members of specific binding pairs
US5447851B1 (en) 1992-04-02 1999-07-06 Univ Texas System Board Of Dna encoding a chimeric polypeptide comprising the extracellular domain of tnf receptor fused to igg vectors and host cells
ZA932522B (en) 1992-04-10 1993-12-20 Res Dev Foundation Immunotoxins directed against c-erbB-2(HER/neu) related surface antigens
US5643570A (en) 1992-05-19 1997-07-01 Xoma Corporation BPI-immunoglobulin fusion proteins
DK1621554T4 (da) 1992-08-21 2012-12-17 Univ Bruxelles Immunoglobuliner blottet for lette kæder
US6005079A (en) 1992-08-21 1999-12-21 Vrije Universiteit Brussels Immunoglobulins devoid of light chains
CA2141602A1 (en) 1992-08-26 1994-03-03 Philip Leder Use of the cytokine ip-10 as an anti-tumor agent
US5639641A (en) 1992-09-09 1997-06-17 Immunogen Inc. Resurfacing of rodent antibodies
EP0627932B1 (en) 1992-11-04 2002-05-08 City Of Hope Antibody construct
US5934272A (en) 1993-01-29 1999-08-10 Aradigm Corporation Device and method of creating aerosolized mist of respiratory drug
ES2162863T3 (es) 1993-04-29 2002-01-16 Unilever Nv Produccion de anticuerpos o fragmentos (funcionalizados) de los mismos derivados de inmunoglobulinas de cadena pesada de camelidae.
WO1995015982A2 (en) 1993-12-08 1995-06-15 Genzyme Corporation Process for generating specific antibodies
DE69534347T2 (de) 1994-01-31 2006-05-24 Trustees Of Boston University, Boston Bibliotheken aus Polyklonalen Antikörpern
US5834252A (en) 1995-04-18 1998-11-10 Glaxo Group Limited End-complementary polymerase reaction
US5605793A (en) 1994-02-17 1997-02-25 Affymax Technologies N.V. Methods for in vitro recombination
US5837458A (en) 1994-02-17 1998-11-17 Maxygen, Inc. Methods and compositions for cellular and metabolic engineering
US5516637A (en) 1994-06-10 1996-05-14 Dade International Inc. Method involving display of protein binding pairs on the surface of bacterial pili and bacteriophage
HUT76369A (en) 1994-07-29 1997-08-28 Smithkline Beecham Corp Novel soluble protein compounds
US6962686B2 (en) 1994-10-12 2005-11-08 California Institute Of Technology Cell-specific gene delivery vehicles
US6019968A (en) 1995-04-14 2000-02-01 Inhale Therapeutic Systems, Inc. Dispersible antibody compositions and methods for their preparation and use
JP3517495B2 (ja) 1995-10-12 2004-04-12 トヨタ自動車株式会社 金型鋳造用離型剤
JP2978435B2 (ja) 1996-01-24 1999-11-15 チッソ株式会社 アクリロキシプロピルシランの製造方法
ATE508733T1 (de) 1996-03-04 2011-05-15 Penn State Res Found Materialien und verfahren zur steigerung der zellulären internalisierung
AU5711196A (en) 1996-03-14 1997-10-01 Human Genome Sciences, Inc. Apoptosis inducing molecule i
JP4046354B2 (ja) 1996-03-18 2008-02-13 ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム 増大した半減期を有する免疫グロブリン様ドメイン
CA2248868A1 (en) 1996-03-22 1997-09-25 Human Genome Sciences, Inc. Apoptosis inducing molecule ii
US5874064A (en) 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
US5855913A (en) 1997-01-16 1999-01-05 Massachusetts Instite Of Technology Particles incorporating surfactants for pulmonary drug delivery
US5985309A (en) 1996-05-24 1999-11-16 Massachusetts Institute Of Technology Preparation of particles for inhalation
GB9623820D0 (en) 1996-11-16 1997-01-08 Secr Defence Surface plasma resonance sensor
WO1998023289A1 (en) 1996-11-27 1998-06-04 The General Hospital Corporation MODULATION OF IgG BINDING TO FcRn
CA2277801C (en) 1997-01-16 2002-10-15 Massachusetts Institute Of Technology Preparation of particles for inhalation
US6277375B1 (en) 1997-03-03 2001-08-21 Board Of Regents, The University Of Texas System Immunoglobulin-like domains with increased half-lives
US5896619A (en) 1997-08-29 1999-04-27 General Electric Company Refrigerator door hinge and closure mechanism
CA2309541C (en) 1997-11-03 2011-01-11 Human Genome Sciences, Inc. Vegi, an inhibitor of angiogenesis and tumor growth
JP2002518663A (ja) 1998-05-20 2002-06-25 グラッフィニティ ファルマシューティカル デザイン ゲーエムベーハー 液体状態で存在する多数の試料を同時に測定するためのｓｐｒセンサー
US6289286B1 (en) 1998-05-29 2001-09-11 Biacore Ab Surface regeneration of biosensors and characterization of biomolecules associated therewith
WO1999066903A2 (en) 1998-06-24 1999-12-29 Advanced Inhalation Research, Inc. Large porous particles emitted from an inhaler
US6311415B1 (en) 1998-09-14 2001-11-06 Lind Shoe Company Bowling shoe with replaceable tip
US6319691B1 (en) 1999-06-15 2001-11-20 Usa Universe Bioengineering, Inc. Fusion proteins comprising IFN-alpha2b and TM-alpha1
AU2003244817B2 (en) * 2002-06-28 2010-08-26 Domantis Limited Antigen-binding immunoglobulin single variable domains and dual-specific constructs
JP3803790B2 (ja) 2003-02-17 2006-08-02 株式会社東北テクノアーチ 新規なダイアボディ型二重特異性抗体
EP1609803A4 (en) 2003-03-31 2006-05-24 Chugai Pharmaceutical Co Ltd MODIFIED ANTIBODY AGAINST CD22 AND APPLICATIONS THEREOF
AU2003259718A1 (en) 2003-08-07 2005-03-07 Epitomics, Inc. Methods for humanizing rabbit monoclonal antibodies
US7217348B2 (en) 2003-08-21 2007-05-15 Rensselaer Polytechnic Institute Methods of identifying kinetically stable proteins
ES2971647T3 (es) 2005-04-15 2024-06-06 Macrogenics Inc Diacuerpos covalentes y usos de los mismos

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001030393A2 (en) * 1999-10-22 2001-05-03 Ludwig Institute For Cancer Research Methods for reducing the effects of cancers that express a33 antigen using a33 antigen specific immunoglobulin products
WO2001031065A1 (en) * 1999-10-22 2001-05-03 The Scripps Research Institute Humanization of non-human, mammalian antibodies
WO2004016740A2 (en) * 2002-08-15 2004-02-26 Epitomics, Inc. Humanized rabbit antibodies
WO2004091543A2 (en) * 2003-03-04 2004-10-28 Alexion Pharmaceuticals, Inc. Method of treating autoimmune disease by inducing antigen presentation by tolerance inducing antigen presenting cells
US20050048578A1 (en) * 2003-06-26 2005-03-03 Epitomics, Inc. Methods of screening for monoclonal antibodies with desirable activity
WO2006073748A2 (en) * 2004-12-17 2006-07-13 Alexion Pharmaceuticals, Inc. Antibodies against antigen presenting cells and uses thereof
US20060216293A1 (en) * 2005-03-24 2006-09-28 Couto Fernando J R TNFalpha-neutralizing antibodies
WO2008004834A1 (en) * 2006-07-06 2008-01-10 Isu Abxis Co., Ltd Humanized monoclonal antibody highly binding to epidermal growth factor receptor, egf receptor
WO2008016950A2 (en) * 2006-07-31 2008-02-07 Sandisk 3D Llc Method and apparatus for memory array incorporating two data busses for memory array block selection

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
ESTEVES P.J. et al. The Journal of Immunology, vol. 172, pages 1044-1053 (2004) *
MARCHESINI M.I. et al. Microbial Pathogenesis, vol. 37, pages 95-105 (2004) *
POSPISIL R. et al. Cellular Immunology, vol. 185, pages 93-100 (1998) *
RADER C. et al. The Journal of Biological Chemistry, vol. 275, pages 13668-13676 (2000) *
ROBBEN J. et al. Gene, vol. 126, pages 109-113 (1993) *
SILVA F.A.D. et al. Journal of Molecular Biology, vol. 340, pages 525-542 (2004) *

Also Published As

Publication number Publication date
AU2008246442A1 (en) 2008-11-13
WO2008136694A9 (en) 2010-09-02
ES2540807T3 (es) 2015-07-13
EP2164868A1 (en) 2010-03-24
CA2685213C (en) 2017-02-21
WO2008136694A1 (en) 2008-11-13
JP2010525808A (ja) 2010-07-29
SG194368A1 (en) 2013-11-29
US10280211B2 (en) 2019-05-07
CA2685213A1 (en) 2008-11-13
JP2015164940A (ja) 2015-09-17
US20190256578A1 (en) 2019-08-22
US20100136627A1 (en) 2010-06-03
EP2164868B1 (en) 2015-03-25
JP5791895B2 (ja) 2015-10-07
JP2015012869A (ja) 2015-01-22
PT2164868E (pt) 2015-08-04

Similar Documents

Publication Publication Date Title
US20190256578A1 (en) Engineered Rabbit Antibody Variable Domains And Uses Thereof
US7371383B2 (en) Recombinant anti-interleukin-9 antibodies
AU2002248184B2 (en) Molecules with extended half-lives, compositions and uses thereof
CN105037543B (zh) 治疗性dll4结合蛋白
US20050042664A1 (en) Humanization of antibodies
KR102651290B1 (ko) 항-il-5 항체
US20220112276A1 (en) Biosynthetic materials and methods for multidirectional biotransportation
JP2022542391A (ja) 多方向バイオ輸送のための材料及び方法
CA3211501A1 (en) Materials and methods for targeting regulatory t cells for enhancing immune surveillance
AU2014227505A1 (en) Engineered rabbit antibody variable domains and uses thereof
AU2008201419B2 (en) Molecules with extended half-lives, compositions and uses thereof
CA2766160A1 (en) Modified molecules with increased affinity for fcrn, compositions, and uses thereof
HK40061359B (zh) 靶向c5ar的抗体

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)